International Journal of Pharmaceutics, 0378-5173

Journal

View graph of relations

Related Publications
  1. Learning from Parkinson's patients: Usability of the Cyclops dry powder inhaler

    Luinstra, M., Isufi, V., de Jong, L., Rutgers, A. W. F., Hagedoorn, P., Puttenstein, J., van Laar, T. & Frijlink, H. W., 15-Aug-2019, In : International Journal of Pharmaceutics. 567, p. 118493 5 p., 118493.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. The mechanism behind the biphasic pulsatile drug release from physically mixed poly(DL-lactic(-co-glycolic) acid)-based compacts

    Beugeling, M., Grasmeijer, N., Born, P. A., van der Meulen, M., van der Kooij, R. S., Schwengle, K., Baert, L., Amssoms, K., Frijlink, H. W. & Hinrichs, W. L. J., 15-Nov-2018, In : International Journal of Pharmaceutics. 551, 1-2, p. 195-202 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Challenges for pulmonary delivery of high powder doses

    Sibum, I., Hagedoorn, P., de Boer, A. H., Frijlink, H. W. & Grasmeijer, F., 5-Sep-2018, In : International Journal of Pharmaceutics. 548, 1, p. 325-336 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium

    Gholizadeh, S., Kamps, J. A. A. M., Hennink, W. E. & Kok, R. J., 15-Sep-2018, In : International Journal of Pharmaceutics. 548, 2, p. 747-758 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (136) »

ID: 16303094